Shop

A new dimension in BPH management

Action:

Management of benign prostatic hyperplasia (BPH): The pharmacological actions of Himplasia inhibit the enzyme 5α-reductase, which results in increased levels of testosterone. Drugs that inhibit the 5α-reductase enzyme have been traditionally used in the management of BPH, prostate cancer and baldness. The drug significantly reduces prostatic weight, epithelial (the outer layer of cells that cover open surfaces on the body) height and stromal (connective tissue supporting the framework of an organ) proliferation.

Reduces the symptoms of BPH: Urinary tract infections, dysuria (painful urination), local and internal inflammation are the common symptoms of BPH. Himplasia has anti-inflammatory and antispasmodic properties that relieve BPH-induced inflammation and pain. Due to its antimicrobial property, the medicine prevents urinary tract infections which results due to urine stagnation in the body.